ALNYLAM PHARMACEUTICALS, INC. (ALNY) /
The cash flow of ALNYLAM PHARMACEUTICALS, INC. over the past 10 years
Chart ALNYLAM PHARMACEUTICALS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, ALNYLAM PHARMACEUTICALS, INC.'s operating cash flow was $524.08M and its capital expenditures $58.7M, leaving free cash flow of $465.38M. Free cash flow was above zero in 2 of the 10 years shown. It ranged from -$718.07M in fiscal 2021 to $465.38M in fiscal 2025. Capital expenditures were highest in fiscal 2019, at $140.16M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $524.08M | $58.7M | $465.38M |
| 2024ended Dec 31, 2024 | -$8.31M | $34.28M | -$42.59M |
| 2023ended Dec 31, 2023 | $104.16M | $62.21M | $41.95M |
| 2022ended Dec 31, 2022 | -$541.27M | $72.06M | -$613.33M |
| 2021ended Dec 31, 2021 | -$641.69M | $76.37M | -$718.07M |
| 2020ended Dec 31, 2020 | -$614.96M | $70.36M | -$685.32M |
| 2019ended Dec 31, 2019 | -$278.43M | $140.16M | -$418.58M |
| 2018ended Dec 31, 2018 | -$562.62M | $126.89M | -$689.5M |
| 2017ended Dec 31, 2017 | -$382.79M | $104.21M | -$487M |
| 2016ended Dec 31, 2016 | -$307.7M | $64.56M | -$372.26M |
Fiscal years as ALNYLAM PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ALNYLAM PHARMACEUTICALS, INC.
- The revenue of ALNYLAM PHARMACEUTICALS, INC.
- The profitability of ALNYLAM PHARMACEUTICALS, INC.
- The debt of ALNYLAM PHARMACEUTICALS, INC.
- All of ALNYLAM PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- NTRSNORTHERN TRUST CORP
- WTWWILLIS TOWERS WATSON PLC
- RJFRAYMOND JAMES FINANCIAL, INC.
- MLMMARTIN MARIETTA MATERIALS INC
- HPQHP INC.
Not investment advice. This page shows what ALNYLAM PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.